Novo Nordisk reports strong sales of Wegovy, propelling shares up 9%. Despite supply constraints, volumes are expected to ...

Medical guidelines support the use of new incretin-based medications like Wegovy, Ozempic and Mounjaro to manage the interrelated metabolic conditions of diabetes, obesity and cardiovascular disease.

When it comes to weight loss, finding the right solution can feel like searching for a needle in a haystack. For many, Ozempic has emerged as a standout ...

Share on Pinterest LeoPatrizi/Getty Images Semaglutide is the active ingredient in Wegovy, Ozempic ... but long-term success requires other weight management strategies. Even with healthy ...

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

Wall Street analysts were impressed by data showing competitive rates of weight loss for Viking’s therapy, but shares in the ...

For much of 2024, Novo Nordisk has been crediting Ozempic and Wegovy with the company's success. But just a couple of days ago, Novo quietly announced a major update regarding Rybelsus.

In its analysis, the Institute for Strategic Dialogue pointed to a recent viral X post in which white nationalist Nick ...

Novo Nordisk has achieved great success in weight management thanks to its diabetes and obesity care medications, Ozempic and Wegovy. Viking Therapeutics is looking to make inroads in the obesity ...

Semaglutide (GLP-1) weight-loss drug Wegovy, made by pharmaceutical company Novo Nordisk. (Photo: James Manning/PA Images via ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so what was that journey like for the scientists involved? Obesity has ...

For much of 2024, Novo Nordisk has been crediting Ozempic and Wegovy with the company's success. But just a couple ... Image source: Getty Images. Right now, GLP-1 agonists are primarily focused ...